Cris LaPierre
|
|
lab:
(801) 587-4817 email: crislapi@abl.med.utah.edu |
Education:
Ph.D. Candidate, Bio-Engineering Dec 2009
B.S., Mechanical Engineering Dec 2003
Research Interests:
1. Implementation of bio-instrumentation to simplify and/or automate medical devices.
2. Using neural interfaces to control motor neural prosthetics and provide sensory feedback to the subject.
Selected Work Experience:
University Hospital, Anesthesiology Bioengineering Lab
Bioengineering Research Assistant
October 2004 to present
University of Utah, Bioengineering Department
Teaching Assistant, Heart and Lung Physiology (BE 5000/6000)
Spring 2008, 2006
Teaching
Assistant, Introduction to Matlab (BE 3301)
Spring 2007
Teaching
Assistant, Bioinstrumentation (BE 5101/6101)
Fall 2006
Massachusetts General Hospital Nuclear Magnetic Resonance Imaging Center
Research Assistant with the 7 Tesla group
May 2002 to August 2002, January 2004 to August 2004
Medicaid Outreach Coordinator
July 2000 to May 2002
Honeywell Data Instruments, Inc
Manufacturing Clean Room Assistant
July 1997 to Oct 1997
|
|
Family
Sailing in Boston
Cool Pictures
Publications:
Abstracts
Presented at ASA, ISAP and IARS
1. Johnson K, Syroid N, LaPierre C, Manyam S, Gupta D, Westenskow D, Egan T. Clinical Evaluation of Remifentanil Sevoflurane Response Surfaces in the Non-steady State. Anesthesiology 2007;107:A841.
2. Johnson KB, LaPierre CD, White JL, Egan TD. A Response Surface Model of Remifentanil and Propofol for Esophageal Instrumentation. Anesthesiology 2007;107:A823.
3. Johnson KB, LaPierre CD, White JL, Egan TD. Remifentanil-Propofol Concentrations That Allow Esophageal Instrumentation yet Avoid Unconsciousness. Anesthesiology 2007;107:A18.
4. LaPierre CD, Johnson KB, Egan TD. Simulating Remifentanil-Propofol Dosing Schedules that Allow Esophageal Instrumentation. Anesthesiology 2008;109:A685.
5. Randall B, Johnson K, LaPierre C, Westenskow D, Egan T. Respiratory Compromise Precedes Adequate Anesthesia For Esophageal Instrumentation When Using Remifentanil and Propofol Combinations. Anesthesia and Analgesia 2008;106:S219.
6. LaPierre C, Johnson K, Egan T. Investigation for a Preferred Remifentanil Propofol Combination and Dosing Schedule for Esophageal Instrumentation. Anesthesia and Analgesia 2008;106:S211.
7. LaPierre C, Johnson K, Egan T. Estimating Intersubject Variability for a Remifentanil-Propofol Response Surface of Esophageal Instrumentation. Anesthesia and Analgesia 2008;106:S208.
8. Wiest D, LaPierre C, Syroid N, Johnson K, Gambus P, Jensen E, Egan T, Westenskow D. A Propofol/Remifentanil Pharmacodynamic Model Predicts Patient Response to Endoscopy. Anesthesia and Analgesia 2008;106:S222.
9. Tyler J, LaPierre C, Mangus D, Egan T, Johnson K. BIS Values for Various Remifentanil-Propofol Effect Site Concentrations that Abolish Response to Tibial Pressure. Anesthesia and Analgesia 2009;108:S306.
Papers presented at NASA Space
Grant Consortium
1. LaPierre C, Brewer L, Orr J. Measuring Cardiac
Output Non-Invasively Using the Collier CO2 Rebreathing Method 11th Annual
Rocky Mountain NASA Space Grant Consortium: Fellowship Symposium.
2. LaPierre C, Brewer L, Orr J.
Quantifying the Affect of Leaked CO2 on the NICO Capnostat 12th Annual Rocky
Mountain NASA Space Grant Consortium: Fellowship Symposium.
3. LaPierre C. Comparison of 3D Response
Surface Models: Can Bougie Tolerance Be Predicted From Electric Tetany? 13th
Annual Rocky Mountain NASA Space Grant Consortium: Fellowship Symposium.
4. LaPierre C, Johnson K. Development of a
Cost Functional for Evaluation of Remifentanil-Propofol Dosing Simulations of
Esophageal Instrumentation in the Moderate Sedation Range 14th Annual Rocky
Mountain NASA Space Grant Consortium: Fellowship Symposium.